The DOI matches its Crossref record; 35 of the 35 references it cites were found in a registry or an index.
Mapping of global, regional and national incidence, mortality and mortality-to-incidence ratio of lung cancer in 2020 and 2050
Open accessAbstract
AIM: Lung cancer is the leading cause of cancer deaths worldwide. This study examines the current and future burden of lung cancer at global, regional, and national levels. METHODS: The estimates of lung cancer incident cases, deaths, and their age-standardized rates are drawn from GLOBOCAN 2020 for 21 regions and 185 countries. Mortality-to-incidence ratio (MIR) is considered as a proxy indicator of 5-year survival rates. Lung cancer burden in 2050 is projected using age-specific incidence and death rates in 2020. RESULTS: In 2020, there were 2.21 million new cases and 1.8 million deaths due to lung cancer worldwide with age-standardized incidence rate (ASIR) of 22.4/100,000 (male: 31.5; female: 14.6) and age-standardized mortality rates (ASMR) of 18.0/100,000, (male: 25.9; female: 11.2/100,000). Global MIR of lung cancer was 0.82 (males 0.83; females: 0.79), varying from 0.59 (Japan) to 1.0 (Belize). Hungary had the highest age-standardized rates (ASIR: 50.1/100,000; ASMR: 42.4/100,000) and Nigeria (ASIR: 0.88; ASMR: 0.86) had the lowest age-standardized rates in 2020. Both ASIR and ASMR were positively correlated with country-level tobacco smoking prevalence and human development index (HDI), whereas MIR exhibited a negative correlation with HDI. As per our projections, there will be 3.8 million incident cases and 3.2 million deaths globally due to lung cancer in 2050. CONCLUSION: With close to 2 million cases and deaths already in 2020, lung cancer has already become a global public health threat. Even with current risk levels and age-specific rates, lung cancer annual cases are expected to reach 3.8 million in 2050. Until smoking prevalence is reduced and ambient air pollution levels are checked, particularly in low/medium HDI countries, the lung cancer epidemic will continue unfolding.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Sung, H., Ferlay, J., Siegel, R. L., Laversanne, M., Soerjomataram, I., Jemal, A., & Bray, F. (2021) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.21660 · Cited by 108,699
Siegel, R. L., Miller, K. D., & Jemal, A. (2020) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.21590 · Cited by 20,444
Reduced Lung-Cancer Mortality with Low-Dose Computed Tomographic Screening
The National Lung Screening Trial Research Team (2011) · New England Journal of Medicine · doi:10.1056/nejmoa1102873 · Cited by 11,064
Allemani, C., Matsuda, T., Di Carlo, V., Harewood, R., Matz, M., Nikšić, M., Bonaventure, A., Valkov, M., Johnson, C. J., Estève, J., et al. (2018) · The Lancet · doi:10.1016/s0140-6736(17)33326-3 · Cited by 6,145
Cancer statistics for the year 2020: An overview
Ferlay, J., Colombet, M., Soerjomataram, I., Parkin, D. M., Piñeros, M., Znaor, A., & Bray, F. (2021) · International Journal of Cancer · doi:10.1002/ijc.33588 · Cited by 5,689
Screening for Lung Cancer: U.S. Preventive Services Task Force Recommendation Statement
Moyer, V. A., & on behalf of the U.S. Preventive Services Task Force* (2014) · Annals of Internal Medicine · doi:10.7326/m13-2771 · Cited by 2,632
The carcinogenicity of outdoor air pollution
Loomis, D., Grosse, Y., Lauby-Secretan, B., Ghissassi, F. E., Bouvard, V., Benbrahim-Tallaa, L., Guha, N., Baan, R., Mattock, H., & Straif, K. (2013) · The Lancet Oncology · doi:10.1016/s1470-2045(13)70487-x · Cited by 1,354
A descriptive model of the cigarette epidemic in developed countries
Lopez, A. D., Collishaw, N. E., & Piha, T. (1994) · Tobacco Control · doi:10.1136/tc.3.3.242 · Cited by 1,173
Gridelli, C., Rossi, A., Carbone, D. P., Guarize, J., Karachaliou, N., Mok, T., Petrella, F., Spaggiari, L., & Rosell, R. (2015) · Nature Reviews Disease Primers · doi:10.1038/nrdp.2015.9 · Cited by 1,083
The Mortality of Doctors in Relation to Their Smoking Habits
Doll, R., & Hill, A. B. (1954) · BMJ · doi:10.1136/bmj.1.4877.1451 · Cited by 922
Turner, M. C., Andersen, Z. J., Baccarelli, A., Diver, W. R., Gapstur, S. M., Pope, C. A., Prada, D., Samet, J., Thurston, G., & Cohen, A. (2020) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.21632 · Cited by 844
Tobacco smoking and cancer: a brief review of recent epidemiological evidence
Sasco, A. J., Secretan, M. B., & Straif, K. (2004) · Lung Cancer · doi:10.1016/j.lungcan.2004.07.998 · Cited by 804
Overdiagnosis in Low-Dose Computed Tomography Screening for Lung Cancer
Patz, E. F., Pinsky, P., Gatsonis, C., Sicks, J. D., Kramer, B. S., Tammemägi, M. C., Chiles, C., Black, W. C., & Aberle, D. R. (2014) · JAMA Internal Medicine · doi:10.1001/jamainternmed.2013.12738 · Cited by 776
The epidemiology of lung cancer
de Groot, P. M., Wu, C. C., Carter, B. W., & Munden, R. F. (2018) · Translational Lung Cancer Research · doi:10.21037/tlcr.2018.05.06 · Cited by 716
Wellmann, K. F. (1964) · PubMed · Cited by 691
Cost-Effectiveness of CT Screening in the National Lung Screening Trial
Black, W. C., Gareen, I. F., Soneji, S. S., Sicks, J. D., Keeler, E. B., Aberle, D. R., Naeim, A., Church, T. R., Silvestri, G. A., Gorelick, J., et al. (2014) · New England Journal of Medicine · doi:10.1056/nejmoa1312547 · Cited by 544
Pastorino, U., Silva, M., Sestini, S., Sabia, F., Boeri, M., Cantarutti, A., Sverzellati, N., Sozzi, G., Corrao, G., & Marchianò, A. (2019) · Annals of Oncology · doi:10.1093/annonc/mdz117 · Cited by 523
Higher Lung Cancer Incidence in Young Women Than Young Men in the United States
Jemal, A., Miller, K. D., Ma, J., Siegel, R. L., Fedewa, S. A., Islami, F., Devesa, S. S., & Thun, M. J. (2018) · New England Journal of Medicine · doi:10.1056/nejmoa1715907 · Cited by 462
Epidemiology of lung cancer and lung cancer screening programs in China and the United States
Yang, D., Liu, Y., Bai, C., Wang, X., & Powell, C. A. (2020) · Cancer Letters · doi:10.1016/j.canlet.2019.10.009 · Cited by 327
Deng, Y., Zhao, P., Zhou, L., Xiang, D., Hu, J., Liu, Y., Ruan, J., Ye, X., Zheng, Y., Yao, J., et al. (2020) · Journal of Hematology & Oncology · doi:10.1186/s13045-020-00915-0 · Cited by 259
Long-Term Exposure to Traffic-Related Air Pollution and Lung Cancer Risk
Beelen, R., Hoek, G., van den Brandt, P. A., Goldbohm, R. A., Fischer, P., Schouten, L. J., Armstrong, B., & Brunekreef, B. (2008) · Epidemiology · doi:10.1097/ede.0b013e318181b3ca · Cited by 219
Relationship between exposure to PM2.5 and lung cancer incidence and mortality: A meta-analysis
Huang, F., Pan, B., Wu, J., Chen, E., & Chen, L. (2017) · Oncotarget · doi:10.18632/oncotarget.17313 · Cited by 215
Lung cancer in never smokers—the East Asian experience
Zhou, F., & Zhou, C. (2018) · Translational Lung Cancer Research · doi:10.21037/tlcr.2018.05.14 · Cited by 201
Tobacco Smoking and Mortality in Asia: A Pooled Meta-analysis
Yang, J. J., Yu, D., Wen, W., Shu, X.-O., Saito, E., Rahman, S., Gupta, P. C., He, J., Tsugane, S., Xiang, Y.-B., et al. (2019) · JAMA Network Open · doi:10.1001/jamanetworkopen.2019.1474 · Cited by 173
Kramer, B. S., Berg, C. D., Aberle, D. R., & Prorok, P. C. (2011) · Journal of Medical Screening · doi:10.1258/jms.2011.011055 · Cited by 169
Bray, F. I., & Weiderpass, E. (2010) · International Journal of Cancer · doi:10.1002/ijc.24855 · Cited by 167
Zheng, W., McLerran, D., Rolland, B., Fu, Z., Boffetta, P., He, J., Gupta, P. C., Ramadas, K., Tsugane, S., Irie, F., et al. (2014) · PLoS Medicine · doi:10.1371/journal.pmed.1001631 · Cited by 156
Familial Aggregation of Common Sequence Variants on 15q24-25.1 in Lung Cancer
Liu, P., Vikis, H. G., Wang, D., Lu, Y., Wang, Y., Schwartz, A. G., Pinney, S. M., Yang, P., de Andrade, M., Petersen, G. M., et al. (2008) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/djn268 · Cited by 154 · cited 2×
“About 8% of lung cancer is inherited or occur due to genetic predisposition [9, 10].”
BackgroundFamilial Risk of Lung Carcinoma in the Icelandic Population
Jónsson, S. (2004) · JAMA · doi:10.1001/jama.292.24.2977 · Cited by 127
Kutikova, L., Bowman, L., Chang, S., Long, S. R., Obasaju, C. K., & Crown, W. H. (2005) · Lung Cancer · doi:10.1016/j.lungcan.2005.06.005 · Cited by 124
PRIMARY MALIGNANT GROWTHS OF THE LUNGS AND BRONCHI
ADLER, I. (1912) · The American Journal of the Medical Sciences · doi:10.1097/00000441-191212000-00021 · Cited by 114
Air Pollution from Traffic and Risk for Lung Cancer in Three Danish Cohorts
Raaschou‐Nielsen, O., Bak, H., Sørensen, M., Jensen, S. S., Ketzel, M., Hvidberg, M., Schnohr, P., Tjønneland, A. M., Overvad, K., & Loft, S. H. (2010) · Cancer Epidemiology Biomarkers & Prevention · doi:10.1158/1055-9965.epi-10-0036 · Cited by 89
Age of smoking initiation among adolescents in Africa
Veeranki, S. P., John, R. M., Ibrahim, A., Pillendla, D., Thrasher, J. F., Owusu, D., Ouma, A. E. O., & Mamudu, H. M. (2016) · International Journal of Public Health · doi:10.1007/s00038-016-0888-7 · Cited by 34
Ruano‐Raviña, A., Heleno, B., & Fernández‐Villar, A. (2014) · Journal of Epidemiology & Community Health · doi:10.1136/jech-2014-204293 · Cited by 22
An Emerging Syndemic of Smoking and Cardiopulmonary Diseases in People Living with HIV in Africa
Peprah, E. K., Armstrong-Hough, M. J., Cook, S., Mukasa, B., Taylor, J. Y., Xu, H., Chang, L., Gyamfi, J., Ryan, N., Ojo, T., et al. (2021) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph18063111 · Cited by 17
Cited by
Global Disparities of Cancer and Its Projected Burden in 2050
Bizuayehu, H. M., Ahmed, K. Y., Kibret, G. D., Dadi, A. F., Belachew, S. A., Bagade, T., Tegegne, T. K., Venchiarutti, R. L., Kibret, K. T., Hailegebireal, A. H., et al. (2024) · JAMA Network Open · doi:10.1001/jamanetworkopen.2024.43198 · Cited by 407
Metadata
- Authors
- Sharma, R.
- Venue
- International Journal of Clinical Oncology
- Published
- 2022-01-12
- Volume
- 27
- Issue
- 4
- Pages
- 665-675
- ISSN
- 1341-9625 (ISSN-L)
- 1437-7772
- OpenAlex
- W4205602022
- Cited by
- 265
- References
- 35
- FWCI
- 19.30
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.